75887-0
LOINC Code
| LOINC code | 75887-0 | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| name | |||||||||||||||||||||||||||||||||||||||
| description | Panel for qualitative or quantitative tests for Hepatitis C virus antibody using immunoblot assay (IB) laboratory method. This panel was created for Meaningful Use 3 as part of a project by the American Medical Association (AMA) to develop three Clinical Quality Measures for Hepatitis C - 1) One-Time Screening for HCV for Patients at Risk, 2) HCV Screening for Active Injection Drug Users, and 3) Appropriate Screening Follow-up for Patients with HCV Infection. This concept may be used by a physician to document that he/she has reviewed the HCV antibody confirmatory test results performed using immunoblotting assay (IB) [RIBA] and performed by an outside lab. When the physician does not know which specific LOINC code to choose when documenting the test and results from the lab report, this more generic LOINC panel code can be used. The HCV antibody RIBA panel includes all antibody tests performed using immunoblotting assay (IB) method. In the eMeasure, this LOINC panel and associated LOINCs codes will be included in a larger value set for the specific type of screening - HCV RIBA Test. | ||||||||||||||||||||||||||||||||||||||
| status | ACTIVE | ||||||||||||||||||||||||||||||||||||||
Fully-Specified Name | |||||||||||||||||||||||||||||||||||||||
| component | HCV antibody RIBA tests - Meaningful Use set | ||||||||||||||||||||||||||||||||||||||
| property | - | ||||||||||||||||||||||||||||||||||||||
| time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||||||||||||||||||||||||||||||||||||||
| system | ^Patient | ||||||||||||||||||||||||||||||||||||||
| scale | - | ||||||||||||||||||||||||||||||||||||||
| method | IB = Immune Blot: Applies to techniques that include electrophoretic or chromatographic separation such that position (size) of the band is part of the assessment | ||||||||||||||||||||||||||||||||||||||
Additional Names | |||||||||||||||||||||||||||||||||||||||
| short name | Ab; Blt; HCV Ab RIBA MU Set; Hepatology; ID; Immune blot; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; Panel; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; WB; WBLOT; West blot; West blt; Western blo | ||||||||||||||||||||||||||||||||||||||
Basic Attributes | |||||||||||||||||||||||||||||||||||||||
| class | PANEL.MICRO | ||||||||||||||||||||||||||||||||||||||
| type | 1 Laboratory | ||||||||||||||||||||||||||||||||||||||
| order vs. observation | HCV Ab RIBA MU | ||||||||||||||||||||||||||||||||||||||
Panel Components | |||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
History/Usage | |||||||||||||||||||||||||||||||||||||||
| first released | |||||||||||||||||||||||||||||||||||||||
| last updated | 2.58 | ||||||||||||||||||||||||||||||||||||||
| last change type | MIN - change to field other than name | ||||||||||||||||||||||||||||||||||||||
Related Names | |||||||||||||||||||||||||||||||||||||||
Copyright © 2026 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2026, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com